Delighted to be awarded best proffered paper but would not be possible without the amazing team I work with. Ebison Chinherende, Derya Yucel, @andygaya@GenesisCare
🎉 Congrats to Dr @eminowicz for winning Best Proffered Paper at #UKIO2025!
👏Her work on adaptive MRI-guided SABR in gynae cancers was recognised as one of the top presentations.
Oncologists: Learn more & get MRL credentialled: https://t.co/Gc3g7BBUql
🧪 IGCS Education360 Journal Club
📖 Featured Study: GCIG INTERLACE Trial
Explore the findings on induction chemotherapy followed by standard chemoradiotherapy vs. chemoradiotherapy alone in patients with locally advanced cervical cancer.
🎙️ With experts:
👩⚕️ Mary McCormack, PhD
👩⚕️ Gemma Eminowicz, MD
Join the conversation. Read the article and stay informed with IGCS Journal Club.
📲 https://t.co/eNDHLjG8i4
🎥 Curious how we're transforming gynae cancer care with MR-guided SABR? @eminowicz & Ebison Chinherende show how MR Linac tech is driving precision & adaptability in treatment. If you're a clinician wanting to drive innovation in cancer care, watch now👉🏿https://t.co/bBiJAq3AIO
Feeing privileged to work with such a progressive team keen to push the boundaries of patient care- expanded access for non insured UK residents now available for patients unable to have brachy boost. Please refer. @GenesisCare
🎉 Congrats to @eminowicz for presenting our MR-guided SABR boost pathway for gynae cancers at #UKIO2025! A leap forward in precision radiotherapy, improving outcomes when brachytherapy isn’t an option.
📥 Download poster & slides here: https://t.co/tAos2VNGRR
So delighted for Mary McCormack being named in the Time100 health - so well deserved for tireless determination to improve the care of gynaecological cancer patients worldwide. Thank you for everything. https://t.co/Ir2mWaxcpx
3,000+ cervical cancer cases are diagnosed annually in the UK. GenesisCare’s @eminowicz joined @RadChatPod to discuss MR-guided SABR as an option when brachytherapy isn’t possible. Listen here: https://t.co/JPO0WaghVx
Cervical Cancer treatment studies show no survival advantage of chemoradiotherapy over radiotherapy alone. These results support a more selective approach, reducing unnecessary toxicity for patients with intermediate-risk cervical cancer @JAMAOnc
👉 https://t.co/4cxTGHat76
Join our FREE webinar on MR-guided SABR for Gynaecological Malignancies on Tuesday 29 April at 7pm. This is a great opportunity to gain valuable insights into the latest innovations in treating gynaecological malignancies.
Register here 👉🏻 https://t.co/nQ2R8rRoVN
Great to be part of this audit pilot aiming to improve standard of care in treatment for endometrial cancer @BGCS_org@eveappeal
https://t.co/CNiQ1Os1Ki
📢 Brachytherapy at ESTRO 2025! 🚀
From AI-driven workflows to EMBRACE II, explore the latest innovations in brachytherapy. Don’t miss insights on new tech, re-irradiation trends & its role in modern radiotherapy!
📖 Read the interview: https://t.co/gOhPwqTgli
#ESTRO25
Join us at the #BGCSASM2025 in London from 9-11 July. The meeting will feature two important debates from experts in the field.
View the full programme https://t.co/0deYMlpltS and register today https://t.co/7t9nHAHrVi
Interested in management of locally advanced cervical cancer and recent advancements in systemic therapy as well as the EMBRACE perspective? Watch our gyn-SMART webinar
https://t.co/JM9Syk7ZRP
New @simplyoncology episode🖐️🎤🚨Talking endometrial cancer updates from this year!
Spotlight 🔦on DUO-E ?bringing PARPi into met endo ca and KEYNOTE B21 ? Pembro in adj EC space.
Check it out 👇
https://t.co/b4t9hhjxCr
@BGCS_org@ENYGO_official@GynaeCancerUK@RAINBOprogram
Just a reminder to anyone who treats gynae cancer with radiotherapy (physicist/radiographer/clinician etc) please fill out this questionnaire to help us shape the ESTRO focus group objectives 🙏
🔔 Two Weeks Left! Join Us at the GEC-ESTRO Brachytherapy Workshop in Hamburg! 🔔
📅 Nov 28-29, 2024
📍 Hamburg, Germany
📧 For more details or to join a satellite meeting with working group leaders, email: [email protected]
🔗 : https://t.co/dV6fx6VpVr
#ESTROGEC24#Radonc